Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.67	20.55	4.61	56.41	84.83	114.2
Short-Term Investments	89.73	119.63	46.49	-	-	-
Cash & Short-Term Investments	93.4	140.18	51.1	56.41	84.83	114.2
Cash Growth	19.45%	174.31%	-9.41%	-33.51%	-25.71%	1199.00%
Other Receivables	0.75	-	-	-	-	0.11
Receivables	0.75	-	-	-	-	0.11
Prepaid Expenses	2.13	2.82	4.94	3.08	3.48	1.29
Other Current Assets	0.01	0.73	0.09	0.03	0.03	0.04
Total Current Assets	96.3	143.73	56.13	59.52	88.35	115.63
Property, Plant & Equipment	0.69	0.93	0.37	0.74	0.77	0.14
Goodwill	-	-	-	-	48.65	48.65
Other Intangible Assets	32.39	32.39	32.39	32.39	32.39	32.39
Other Long-Term Assets	0.48	0.36	0.19	0.15	0.4	0.38
Total Assets	129.86	177.41	89.07	92.79	170.55	197.19
Accounts Payable	4.63	5.83	0.97	2.2	1.81	1.37
Accrued Expenses	9.32	5.43	2.55	3.91	2.22	0.97
Current Portion of Leases	0.35	0.31	0.38	0.36	0.37	0.14
Total Current Liabilities	14.3	11.58	3.9	6.48	4.4	2.48
Long-Term Leases	0.38	0.64	-	0.38	0.4	-
Long-Term Deferred Tax Liabilities	2.18	2.18	1.75	1.75	1.75	4.11
Other Long-Term Liabilities	21.95	44.87	76.21	-	-	-
Total Liabilities	38.8	59.27	81.86	8.61	6.55	6.59
Common Stock	55.75	0.06	0.02	0.01	0.01	0.02
Additional Paid-In Capital	426.05	473.64	326.59	287.03	278.88	270.97
Retained Earnings	-390.76	-355.59	-319.4	-202.87	-114.9	-80.39
Comprehensive Income & Other	0.01	0.03	-	-	-	-
Shareholders' Equity	91.05	118.14	7.21	84.18	164	190.6
Total Liabilities & Equity	129.86	177.41	89.07	92.79	170.55	197.19
Total Debt	0.72	0.95	0.38	0.75	0.77	0.14
Net Cash (Debt)	92.68	139.22	50.72	55.66	84.06	114.05
Net Cash Growth	19.29%	174.50%	-8.88%	-33.78%	-26.29%	1247.01%
Net Cash Per Share	1.23	2.87	2.06	3.90	5.67	78.58
Filing Date Shares Outstanding	59.93	59.88	24.81	13.78	14.31	14.31
Total Common Shares Outstanding	60	59.79	24.21	13.78	14.31	15.16
Working Capital	82.01	132.15	52.23	53.04	83.95	113.15
Book Value Per Share	1.52	1.98	0.30	6.11	11.46	12.57
Tangible Book Value	58.67	85.75	-25.18	51.8	82.96	109.56
Tangible Book Value Per Share	0.98	1.43	-1.04	3.76	5.80	7.23

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q